HomeBLRX • NASDAQ
add
BioLine RX Ltd - ADR
Previous close
$2.42
Day range
$2.36 - $2.53
Year range
$2.28 - $7.77
Market cap
10.74M USD
Avg Volume
13.01K
P/E ratio
-
Dividend yield
-
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 194.00K | -98.35% |
Operating expense | 3.54M | -59.91% |
Net income | -1.38M | 56.54% |
Net profit margin | -713.92 | -2,531.48% |
Earnings per share | 0.00 | — |
EBITDA | -3.32M | -72.18% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 20.88M | 6.72% |
Total assets | 40.90M | 5.14% |
Total liabilities | 17.56M | -30.99% |
Total equity | 23.34M | — |
Shares outstanding | 2.66B | — |
Price to book | 242.00 | — |
Return on assets | -20.98% | — |
Return on capital | -26.29% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -1.38M | 56.54% |
Cash from operations | -3.20M | 62.83% |
Cash from investing | -337.00K | -103.02% |
Cash from financing | -1.25M | -12.89% |
Net change in cash | -4.66M | -391.50% |
Free cash flow | -4.30M | 21.23% |
About
BioLineRx Ltd., or BioLine, is a publicly traded drug development company. Headquartered in Israel, its shares are traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Wikipedia
Founded
2003
Website
Employees
28
